Loading...
XKRX071200
Market cap69mUSD
Jan 09, Last price  
4,175.00KRW
1D
-0.60%
1Q
-2.45%
Jan 2017
-39.14%
IPO
-20.63%
Name

Infinitt Healthcare Co Ltd

Chart & Performance

D1W1MN
XKRX:071200 chart
P/E
5.32
P/S
1.11
EPS
785.12
Div Yield, %
0.00%
Shrs. gr., 5y
-0.07%
Rev. gr., 5y
7.43%
Revenues
92.02b
+4.23%
32,988,178,00040,344,619,00042,816,849,00047,018,577,000109,526,773,250112,776,673,40069,305,124,03062,780,076,47061,794,723,71071,497,682,82072,774,153,71064,315,329,28074,267,024,53070,069,398,67078,169,939,46088,286,336,63092,018,605,210
Net income
19.14b
+14,446.42%
114,819,0001,856,112,0004,541,717,0004,993,557,000-3,193,285,000-6,936,490,0008,932,236,3802,212,771,5705,654,857,5007,106,164,9601,544,932,1504,931,380,5207,247,256,8806,682,931,34022,656,483,110131,568,51019,138,510,070
CFO
10.22b
+16.80%
-87,173,0005,818,599,0009,299,881,000-2,905,509,0004,942,565,4402,774,759,3707,490,238,6803,077,566,6106,885,298,7905,744,385,4706,492,545,4106,646,927,49014,904,247,72016,154,960,82015,944,091,0108,752,378,52010,222,624,170

Profile

Infinitt Healthcare Co Ltd is a Korea based company engaged in developing digital solutions used in hospitals. It offers clinical solutions, enterprise imaging solutions and radiology solutions. Clinical solutions cover cardiology PACS, digital pathology solutions, 3D solution, 3D printing service, radiation oncology information solution and others. Radiology solutions include PACS, RIS, Data Analytics solution, Cloud PACS, TeleRadiology solution and others.
URL
https://www.infinittna.com/
IPO date
May 26, 2010
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
92,018,605
4.23%
88,286,337
12.94%
Cost of revenue
57,015,520
50,798,809
Unusual Expense (Income)
NOPBT
35,003,085
37,487,527
NOPBT Margin
38.04%
42.46%
Operating Taxes
3,971,790
(3,256,165)
Tax Rate
11.35%
NOPAT
31,031,295
40,743,692
Net income
19,138,510
14,446.42%
131,569
-99.42%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
2,023,137
2,029,099
Long-term debt
4,480,894
5,474,990
Deferred revenue
Other long-term liabilities
5,785,082
3,548,350
Net debt
(7,964,353)
(25,634,710)
Cash flow
Cash from operating activities
10,222,624
8,752,379
CAPEX
(717,788)
(525,022)
Cash from investing activities
(26,353,524)
11,996,229
Cash from financing activities
(1,492,438)
(1,848,666)
FCF
38,917,909
39,159,640
Balance
Cash
106,815,951
81,199,576
Long term investments
(92,347,566)
(48,060,777)
Excess cash
9,867,454
28,724,482
Stockholders' equity
102,156,906
83,331,910
Invested Capital
133,620,057
93,887,597
ROIC
27.28%
40.52%
ROCE
24.39%
30.57%
EV
Common stock shares outstanding
24,326
26,314
Price
5,170.00
-5.83%
5,490.00
-23.43%
Market cap
125,765,906
-12.94%
144,462,224
-17.47%
EV
117,798,115
118,535,213
EBITDA
37,501,286
40,048,057
EV/EBITDA
3.14
2.96
Interest
133,729
121,791
Interest/NOPBT
0.38%
0.32%